This inventor holds 4 USPTO granted patents. Top assignee: Howard Florey Institute of Experimental Physiology and Medicine. Active years: 1989-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1994
Title: John Shine: Innovator in Human Relaxin Research
Introduction
John Shine is a prominent inventor based in Swinger Hill, Australia. He has made significant contributions to the field of experimental physiology and medicine, particularly in the synthesis of human relaxin polypeptides. With a total of 4 patents to his name, Shine's work has advanced our understanding of peptide synthesis and recombinant DNA techniques.
Latest Patents
Shine's latest patents include a process for synthesizing human H1-prorelaxin and H1-relaxin, as well as a fusion of genes and DNA transfer vectors for the expression of human prepororelaxin. These patents also cover subunits for the expression of human prorelaxin and the individual A, B, and C peptide chains, along with methods for synthesizing these peptides using recombinant DNA techniques. His innovative approaches have paved the way for further research in this area.
Career Highlights
John Shine is affiliated with the Howard Florey Institute of Experimental Physiology and Medicine, where he has dedicated his career to advancing medical science. His research has not only contributed to the academic community but has also had practical implications in the field of medicine.
Collaborations
Throughout his career, Shine has collaborated with notable colleagues such as Peter J. Hudson and Hugh D. Niall. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
John Shine's contributions to the field of human relaxin research exemplify the importance of innovation in medicine. His patents and collaborative efforts continue to influence the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile